Alirocumab Proves Beneficial For Lowering High-Cholesterol Levels

January 12, 2015 6:14 AM

18 0

Alirocumab — an experimental cholesterol drug made by Sanofi and Regeneron is proven effective in lowering the amount of Low-density Lipoprotein cholesterol or LDL-C, which is also called bad cholesterol in the body by 30% even if taken once a month rather than the usual two-week interval. The trials are called ODYSSEY trials, and Alirocumab effectively cleared ODYSSEY Choice 1 and ODYSSEY Choice 2.

Some of the side effects noted in the clinical trials include headache, upper respiratory tract infection, nausea, joint pain, sinusitis and fatigue. But the number of people affected was only 5%.

Read more

To category page